Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Millan

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
British Journal of Pharmacology|November 11, 1999
Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinilC Sebban, B Tesolin-Decros, M J Millan, et al.
European Journal of Pharmacology|June 20, 1996
S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptorsA Newman-Tancredi, C Chaput, L Verrièle, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2000
An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletionD Cussac, A Newman-Tancredi, Y Quentric, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 2000
[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptorsD Cussac, A Newman-Tancredi, L Sezgin, et al.
European Journal of Pharmacology|July 27, 2001
Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinaseM J Millan, A Newman-Tancredi, D Duqueyroix, et al.
Psychopharmacology|July 24, 2001
The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptorsM J Millan, A Newman-Tancredi, Y Quentric, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 28, 2001
Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptorsV Audinot, A Newman-Tancredi, D Cussac, et al.
Neuropharmacology|May 30, 2001
Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPATA Dekeyne, J M Rivet, A Gobert, et al.
Journal of Neurochemistry|March 22, 2001
Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in ratsM J Millan, F Lejeune, G De Nanteuil, et al.
Neuropharmacology|July 29, 1998
The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924H J Bengtsson, A Kullberg, M J Millan, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
British Journal of Pharmacology|November 11, 1999
Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinilC Sebban, B Tesolin-Decros, M J Millan, et al.
European Journal of Pharmacology|June 20, 1996
S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptorsA Newman-Tancredi, C Chaput, L Verrièle, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2000
An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletionD Cussac, A Newman-Tancredi, Y Quentric, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 2000
[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptorsD Cussac, A Newman-Tancredi, L Sezgin, et al.
European Journal of Pharmacology|July 27, 2001
Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinaseM J Millan, A Newman-Tancredi, D Duqueyroix, et al.
Psychopharmacology|July 24, 2001
The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptorsM J Millan, A Newman-Tancredi, Y Quentric, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 28, 2001
Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptorsV Audinot, A Newman-Tancredi, D Cussac, et al.
Neuropharmacology|May 30, 2001
Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPATA Dekeyne, J M Rivet, A Gobert, et al.
Journal of Neurochemistry|March 22, 2001
Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in ratsM J Millan, F Lejeune, G De Nanteuil, et al.
Neuropharmacology|July 29, 1998
The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924H J Bengtsson, A Kullberg, M J Millan, et al.
Pageof 23